Second Phase of Alzheimer's test with Neuro-Bio | 22-Feb-2024 | 07:00 | RNS |
Half Year Trading Update | 05-Feb-2024 | 07:00 | RNS |
Holding(s) in Company | 04-Jan-2024 | 14:39 | RNS |
Results of 2023 Annual General Meeting | 15-Dec-2023 | 15:57 | RNS |
AGM Statement | 15-Dec-2023 | 07:00 | RNS |
Material Agreement with Genetic Medicines Company | 14-Dec-2023 | 07:00 | RNS |
Posting of Annual Report and Notice of AGM | 20-Nov-2023 | 07:00 | RNS |
Full year results for the 12mths ended 30 Jun 2023 | 09-Nov-2023 | 07:00 | RNS |
Notice of Results and Investor Presentation | 08-Nov-2023 | 12:20 | RNS |
Trading Update | 06-Nov-2023 | 07:00 | RNS |
Holding(s) in Company | 24-Oct-2023 | 10:16 | RNS |
Grant of Options and Related Party Transaction | 09-Oct-2023 | 09:40 | RNS |
Placing and Subscription, PDMR Dealing and TVR | 19-Sep-2023 | 14:35 | RNS |
Holding(s) in Company | 13-Sep-2023 | 12:58 | RNS |
Holding(s) in Company | 31-Aug-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 0.75p |
Change Today | -0.075p |
% Change | -9.09 % |
52 Week High | 17.50 |
52 Week Low | 0.50 |
Volume | 6,184,391 |
Shares Issued | 467.34m |
Market Cap | £3.51m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:18 | 100,000 @ 0.72p |
16:09 | 45,000 @ 0.72p |
14:51 | 4,758 @ 0.72p |
14:04 | 4,758 @ 0.80p |
13:52 | 56,000 @ 0.72p |
You are here: research